| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$24 |
Appendix 4E and FY25 Financial Statements
|
29 Aug 2025 10:29AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Spacetalk Ltd's total revenue for FY25 was $19.6 million.
- Net loss after tax reduced to $4.5 million for FY25.
- Effective cost management and restructuring reduced operating expenses to $12.5 million.
- Share-based compensation and equity transactions affected financial outcomes.
- Improvements in cash flow due to operational efficiencies and cost savings.
- Capital raises and debt management with Pure Asset Management were key financial strategies.
- Shareholder equity increased through new share issuance and consolidation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,028 |
Appendix 3Y - Denise McComish
|
29 Aug 2025 10:29AM |
$4.490 |
$2.840 |
fallen by
36.75%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$560 |
Appendix 4G and 2025 Corporate Governance Statement
|
29 Aug 2025 10:28AM |
$3.440 |
$2.500 |
fallen by
27.33%
|
|
| Codan Limited (CDA) ORDINARY FULLY PAID |
Information Technology |
$8,003 |
Notification of cessation of securities - CDA
|
29 Aug 2025 10:28AM |
$29.860 |
$44.000 |
risen by
47.35%
|
|
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$4 |
Appendix 4D and Half Year report 30 June 2025
|
29 Aug 2025 10:28AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 147.8% to $1,425,000.
- Net loss after tax rose by 79.8% to $1,057,000.
- Comprehensive loss for the half-year was $1,021,000.
- Total equity decreased to $8,986,000 as of June 2025.
- No dividends were declared during the period.
- Legal proceedings are ongoing, with no reliable estimate of potential financial impact.
- Inventory management includes addressing quality issues in Phoslock® products.
- Cash reserves expected to last for at least eight quarters.
- Segment revenue from US/Canada/Brazil led with $955,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$4 |
Appendix 4D and Half Year report 30 June 2025
|
29 Aug 2025 10:28AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax was $1.057 million.
- Revenue increased by 148% to $1.425 million.
- Strong sales in Brazil contributed significantly to revenue.
- No dividends were declared for the period.
- Net assets were $8.986 million as of 30 June 2025.
- The company is focused on global expansion and market diversification.
- Ongoing investigations by the Australian Federal Police and ASIC.
- Cash reserves are expected to support operations for at least the next eight quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$560 |
2025 Annual Reports and AGM Documentation
|
29 Aug 2025 10:27AM |
$3.440 |
$2.500 |
fallen by
27.33%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$21 |
FY25 Full Year Results & FY26 Guidance Investor Presentation
|
29 Aug 2025 10:27AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue increased by 29% to $11.1M.
- Compounded annual growth rate from FY23 to FY25 was 43%.
- Normalized operating EBITDA of $1.4M, up 24% from FY24.
- $13.8M clinical trial progressing as planned.
- SaMD service agreements worth ~$4.5M in new contracts.
- Cost efficiency program expected to save $1.1M annually.
- FY26 revenue guidance is $17M with $2M EBITDA target.
- Continued growth expected in SaMD, CRO services, and TrialsWest.
- Exploration of new contract opportunities and expansions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$21 |
FY25 Full Year Results & FY26 Guidance Investor Presentation
|
29 Aug 2025 10:27AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue grew 29% to $11.1 million.
- Normalized operating EBITDA increased 24% to $1.4 million.
- Record cash receipts from customers totaled $14 million.
- Major clinical trial contracts secured, including a $13.8 million trial.
- Cost efficiency program completed with $1.1 million projected savings.
- FY26 revenue guidance of $17 million and EBITDA of $2 million.
- Continued expansion in SaMD and clinical trial services.
- Focus on automation to increase business capacity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$21 |
Appendix 4E & Full Year Statutory Accounts
|
29 Aug 2025 10:27AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after tax of AUD 1.73 million for FY 2025.
- Revenue increased to AUD 11.07 million, driven by EMEA sales.
- Net assets decreased from AUD 10.93 million in 2024 to AUD 9.39 million in 2025.
- Investment in MRI-based diagnostic tools and refining existing products.
- Acquisition of TrialsWest impacting cash flows and financial position.
- Significant investments in property, plant, equipment, and intangible assets.
- Amortization and depreciation impacted financial results.
- Company remains focused on leveraging diagnostic innovations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$21 |
Appendix 4E & Full Year Statutory Accounts
|
29 Aug 2025 10:27AM |
$0.041 |
$0.044 |
risen by
7.32%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $1,732,939 for the year ended 30 June 2025.
- Revenue increased to $11,073,018.
- Basic and diluted loss per share at (0.38) cents.
- Net assets valued at $9,390,797.
- Total liabilities amounted to $8,498,850.
- Investments in TrialsWest acquisition.
- New trial site announced in Mandurah, Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codan Limited (CDA) ORDINARY FULLY PAID |
Information Technology |
$8,003 |
Application for quotation of securities - CDA
|
29 Aug 2025 10:25AM |
$29.860 |
$44.000 |
risen by
47.35%
|
|
| Mosaic Brands Limited (MOZ) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.036 |
$0.036 |
fallen by
0%
|
|
| Lucapa Diamond Company Limited (LOM) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Merchant House International Limited (MHI) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.150 |
$0.150 |
fallen by
0%
|
|
| Field Solutions Holdings Limited (FSG) ORDINARY FULLY PAID |
Communication Services |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
| Health and Plant Protein Group Limited (HPP) ORDINARY FULLY PAID |
Consumer Staple |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.042 |
$0.042 |
fallen by
0%
|
|
| Traffic Technologies Ltd (TTI) ORDINARY FULLY PAID |
Industrials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Lepidico Ltd (LPD) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Walkabout Resources Ltd (WKT) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.095 |
$0.095 |
fallen by
0%
|
|
| Strandline Resources Limited (STA) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.095 |
$0.095 |
fallen by
0%
|
|
| Resource Development Group Limited (RDG) ORDINARY FULLY PAID |
Industrials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| Gas2Grid Limited (GGX) ORDINARY FULLY PAID |
Energy |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Inventis Limited (IVT) ORDINARY FULLY PAID |
Industrials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
| Redflow Limited (RFX) ORDINARY FULLY PAID |
Industrials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.097 |
$0.097 |
fallen by
0%
|
|
Call 1300 880 160
Start a chat
Schedule a call
